SCHEMBL20053679

SCHEMBL20053679

CCCCC[C@H]1C(=O)NC2(CC2)C(=O)N[C@H](C(=O)NCC(N)=O)CSCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CN)C(=O)N[C@@H](CC(C)C)C(=O)N2C[C@H](O)C[C@H]2C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCN)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N(C)[C@@H](CCCC)C(=O)N1C

nearest known ligand 0.64

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CD274 Q9NZQ7 9/20 0.64
PDCD1 Q15116 7/20 0.62
CIB1 Q99828 5/20 0.53
KLKB1 P03952 3/20 0.45
PCSK9 Q8NBP7 2/20 0.44
LDLR P01130 1/20 0.44
NECTIN4 Q96NY8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17854747 0.99 CD274 (0.65) CD274PDCD1CIB1KLKB1PCSK9
SCHEMBL17854753 0.98 CD274 (0.65) CD274PDCD1CIB1KLKB1PCSK9
SCHEMBL20052313 0.97 CD274 (0.65) CD274PDCD1CIB1KLKB1PCSK9
SCHEMBL20052309 0.96 CD274 (0.64) CD274PDCD1CIB1KLKB1PCSK9
SCHEMBL20053771 0.96 CD274 (0.69) CD274PDCD1CIB1KLKB1PCSK9
SCHEMBL17854754 0.96 CD274 (0.64) CD274PDCD1CIB1KLKB1PCSK9
SCHEMBL20053744 0.96 CD274 (0.64) CD274PDCD1CIB1KLKB1PCSK9
SCHEMBL20052340 0.96 CD274 (0.68) CD274PDCD1CIB1KLKB1PCSK9
SCHEMBL17854770 0.96 CD274 (0.68) CD274PDCD1CIB1KLKB1PCSK9
SCHEMBL17854752 0.95 CD274 (0.67) CD274PDCD1CIB1KLKB1PCSK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9944678-B2 Immunomodulators BRISTOL-MYERS SQUIBB COMPANY (US) 2018-04-17 US disclosed